8 stocks other than Microsoft, Apple and Nvidia that could be worth $4 trillion in three years
Stocks reaching the top of the market-cap rankings will often follow with below-average growth.
5 ways a financial adviser can keep estate-planning fights from splitting your family
Experts who understand wills and trusts use these resources to guide you.
‘Her world is rocked’: A friend hit the jackpot, but her old friends are abandoning her one by one. Is there a cure for jealousy?
“Is this jealousy or a change in perceived status that has upended her friendships? Any ideas or cures?”
Beat the market and generate income: 6 tips from two portfolio managers with great records
A focus on how companies use cash and a prediction that Amazon.com will start paying a dividend.
Junk bonds are beating the broader market so far in 2024 — but watch this shift
Junk bonds are beating the broader U.S. fixed-income market so far in 2024 — but pummeled Treasurys have attempted a comeback lately.
Forever 21 seeks rent concessions, facing financial struggles
Forever 21 is asking landlords for a break on rent as the legacy fast-fashion player’s sales decline and it struggles to keep up with savvier competitors, CNBC has learned. The retailer, which has more than 380 stores in the U.S., has asked some landlords to cut its rent by as much as 50%, people familiar […]
‘A few motherly words of wisdom can go a long way’: My two adult sons will each inherit $100,000. What should they do with it?
“We live in the greater Boston area, so housing costs are extremely high.”
Citigroup, JPMorgan Chase, Goldman hit by regulators
Jane Fraser, CEO of Citigroup, testifies during the Senate Banking, Housing, and Urban Affairs Committee hearing titled Annual Oversight of the Nations Largest Banks, in Hart Building on Thursday, September 22, 2022. Tom Williams | CQ-Roll Call, Inc. | Getty Images Banking regulators on Friday disclosed that they found weaknesses in the resolution plans of […]
Ardent Health Partners files for IPO
Hospital operator Ardent Health Partners, which is backed by an investment firm founded by the late real-estate magnate Sam Zell, has filed for a initial public offering, according to regulatory documents submitted Friday.
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive […]
